Healthcare
Zai Lab Limited
ZLAB$25.46-2.38%
Price is delayed.
Add to Watchlist
About Zai Lab Limited
Zai Lab is a Chinese biopharmaceutical company that discovers and sells drugs to treat cancer, immune system diseases, brain disorders, and infections. Their marketed products include Zejula for ovarian cancer, VYVGART for muscle weakness disorders, NUZYRA for bacterial pneumonia and skin infections, Optune for brain tumors, Qinlock for stomach tumors, and several other medicines. The company works with major drugmakers like Pfizer and Amgen to develop and commercialize these treatments.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore